tirzepatide trial obesity without diabetes surmount-1 weight loss for Obesity: Highlights from the going from 2.5 to 5 – Presented at #ECO2025: In the – UC Irvine researchers project cardiac

No hair loss : There are a lot of anecdotal reports of hair loss, especially a few months into these medications at standard doses, or some microdoses

Danuglipron reduced HbA1c by 1.04% to 1.57% and weight by 1.93 kg to 5.38 kg

If you will not use the entire vial within 28 days, consider reconstituting with less water to create a higher concentration, allowing smaller volumes per dose and potentially fewer unused portions

Understanding both substances' pharmacological profiles is essential for making informed decisions about concurrent use and recognising potential health implications

Long-term safety beyond 1-2 years is unknown because the trials havent run that long yet

Australian-owned supplier